Ethical considerations in neuroemergency clinical trials

Handbook of Neuroemergency Clinical Trials

Volumn , Issue , 2006, Pages 257-273

  Alves, Wayne M ^a  

^a Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53049110768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012648082-5/50016-2     Document Type: Chapter

References (55)

1. Alves WA Macciocchi SNEthical considerations in clinical neuroscience. Current concepts in neuroclinical trials. Stroke 1996, 27:1903-1909.
2. Macciocchi SN, Alves WA Ethical considerations in neuroclinical trials. Neurosurg Rev 1997, 20:161-170.
3. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects 1964, Ferney-Voltaire, World Medical AssociationWorld Medical Association, (Last Amended October, 2000; Last Clarification, 2004)., The World Medical Association, France, (Last Amended October, 2000; Last Clarification, 2004).
4. Barsan WG, Pancioli AM, Conwit RA Executive summary of the National Institute of Neurological Disorders and Stroke conference on Emergency Neurologic Clinical Trials Network. Ann Emerg Med 2004, 44:407-412.
5. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research 1979, Department of Health Education and Welfare, Washington, D.C.
6. Farah MJ Neuroethics: the practical and the philosophical. Trends Cogn Sci 2005, 9:34-40.
7. Illes J, Raffin TA Neuroethics: an emerging new discipline in the study of brain and cognition. Brain Cogn 2002, 50:341-344.
8. Kulynych J Legal and ethical issues in neuro-imaging research: human subjects protection, medical privacy, and the public communication of research results. Brain Cogn 2002, 50:345-357.
9. Northoff G, Witzel J, Bogerts B Neuroethics-a future discipline?. Nervenarzt 2005.
10. Sententia W Neuroethical considerations: cognitive liberty and converging technologies for improving human cognition. Ann N Y Acad Sci 2004, 1013:221-228.
11. Cooper J The law and ethics of the use of experimental medication in patients incapable of expressing consent: between a rock and a hard place. Med Law 2000, 19:189-195.
12. Foex BA The problem of informed consent in emergency medicine research. Emerg Med J 2001, 18:198-204.
13. Shaul RZ Potato, potato, proxy consent, permission-just don't call the whole thing off. Crit Care 2005, 9:123-124. Epub 2005 Jan 7.
14. Tu JV, Willison DJ, Silver FL, Fang J, Richards JA, Laupacis A, Kapral MK Investigators in the Registry of the Canadian Stroke Network. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 2004, 350:414-421.
15. Vanpee D, Gillet JB, Dupuis M Clinical trials in an emergency setting: implications from the fifth version of the Declaration of Helsinki. J Emerg Med 2004, 26:127-131.
16. Winslade WJ, Tovino SA Research with brain-injured subjects. J Head Trauma Rehabil 2004, 19:513-515.
17. Winslade WJ Research on minimally conscious patients: innovation or exploitation?. J Head Trauma Rehabil 2004, 19:178-179.
18. Office for Human Research Protections Protecting Human Research Subjects: Institutional Review Board Guidebook 2001, June 21, Department of Health and Human Resources.
19. Ijichi S, Ijichi N The scientific establishment of a new therapeutic intervention for developmental conditions: practical and ethical principles. Childs Nerv Syst 2003, 19:711-715.
20. Neill SJ Research with children: a critical review of the guidelines. J Child Health Care 2005, 9:46-58.
21. Koops L, Lindley RI Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. Br Med J 2002, 325:415.
22. Nurock S Patients may be less risk averse than committees. Br Med J 2005, 330:471-472.
23. International Conference on Harmonization E6: Good Clinical Practice: Consolidated Guideline 1997.
24. Code of Federal Regulations 21 CFR 50, 50.24, 50.25(a)(1)-(5), 56, 56.108(e), 56.111(a)(2), 312.7 (dl)-(d2), 312.23(a)(1)(iv), 312.34-35, 312.60, 314.126.
25. Code of Federal Regulations 45 CFR 46 (Sub-part A), 46.103(a), 46.107, 46.109, 46.111, 46.116, 46.402(d), 46.404-409.
26. European Medicines Agency The European Union Directive 2001/20/EC, 4 April 2001. Published in Official Journal of the European Communities 2001, 34-44. 1 May, L121.
27. Gennery B Academic clinical research in the new regulatory environment. Clin Med 2005, 5:39-41.
28. Kompanje EJ, Maas AI, Dippel DW Clinical trials on medical products for human use in the case of acutely incapacitated patients within the fields of neurology and neurosurgery; implications of the new European legislation. Tijdschr Geneeskd 2003, 147:1585-1589.
29. Stocchetti N, Dearden M, Karimi A, Lapierre F, Maas A, Murray GD, Ohman J, Persson L, Servadei F, Trojanowski T, Unterberg A New European directive on clinical trials: implications for traumatic head injury research. Intensive Care Med 2004, 30:517-518. Epub 2004 Jan 16.
30. Warlow C Over-regulation of clinical research: a threat to public health. Clin Med 2005, 5:33-58.
31. Grady C The challenge of assuring continued post-trial access to beneficial treatment. Yale J Health Policy Law Ethics 2005, 5:425-435.
32. La Vaque TJ, Rossiter T The ethical use of placebo controls in clinical research: the Declaration of Helsinki. Appl Psychophysiol Biofeedback 2001, 26:23-37. discussion 61-65.
33. Rothman KJ, Michels KB The continuing unethical use of placebo controls. N Engl J Med 1994, 331:394-398.
34. Guc MO Ethics in publication. Acta Neurochir 2002, 83:101-104. (suppl).
35. Hoeksema HL, Troost J, Grobbee DE, Wiersinga WM, van Wijmen FC, Klasen EC A case of fraud in a neurological pharmaceutical clinical trial. Ned Tijdschr Geneeskd 2003, 147:1372-1377. [in Dutch].
36. Tuech JJ, Pessaux P, Moutel G, Thoma V, Schraub S, Herve C Methodological quality and reporting of ethical requirements in phase III cancer trials. J Med Ethics 2005, 31:251-255.
37. Kansu E, Ruacan S Research ethics and scientific misconduct in biomedical research. Acta Neurochir 2002, 83:11-15. (suppl).
38. Walsh MK, McNeil JJ, Breen KJ Improving the governance of health research. Med J Aust 2005, 182:468-471.
39. Bacchetti P, Wolf LE, Segal MR, McCulloch CE Ethics and sample size. Am J Epidemiol 2005, 161:105-110.
40. Freedman B Equipoise and the ethics of clinical research. N Engl J Med 1987, 317:141-145.
41. Rikkert MG, Lauque S, Frolich L, Vellas B, Dekkers W The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia. Eur J Neurol 2005, 12:212-217.
42. Emanuel EJ, Emanuel LL Proxy decision making for incompetent patients. JAMA 1992, 267:2067-2071.
43. Abramson NS, Safar P Deferred consent: use in clinical resuscitation research. Brain Resuscitation Clinical Trial II Study Group. Ann Emerg Med 1990, 19:781-784.
44. Beauchamp TL, Fost N, Robertson JA The ambiguities of "deferred consent.". IRB 1980, 2:6-9.
45. Fost N, Robertson JA Deferring consent with incompetent patients in an intensive care unit. IRB Rev Hum Subj Res 1980, 2:5-6.
46. Levine RJ Research in emergency situations. The role of deferred consent. JAMA 1995, 273:1300-1302.
47. Levine RJ Deferred consent. Control Clin Trials 1991, 12:546-550.
48. Miller BL The ethics of cardiac arrest research. Ann Emerg Med 1993, 22:118-124.
49. Miller BLPhilosophical, ethical, and legal aspects of resuscitation medicine. I. Deferred consent and justification of resuscitation research. Crit Care Med 1988, 16:1059-1062.
50. Office for Protection from Research Risks OPRR Reports: Informed Consent Requirements in Emergency Research 1996, October 31.
51. Turner G, Lisook AB, Delman DP FDA's conduct, review, and evaluation of inspections of clinical investigators. Drug Inf J 1987, 21:117-125.
52. Arnold LK, Razzak J Research agendas in global emergency medicine. Emerg Med Clin North Am 2005, 23:231-257.
53. Hyder AA, Dawson L Defining standard of care in the developing world: the intersection of international research ethics and health systems analysis. Dev World Bioeth 2005, 5:142-152.
54. Rivera R, Borasky D, Rice R, Carayon F Many worlds, one ethic: design and development of a global research ethics training curriculum. Developing World Bioeth 2005, 5:169-175.
55. Worrall BB, Chen DT, Meschia JF Ethical and methodological issues in pedigree stroke research. Stroke 2001, 32:1242-1249.